lobbying_activities: 2205530

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2205530	b4c5987a-c2d2-4e2d-b936-1e7cb6509d7f	Q3	AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION	1331	AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION	2018	third_quarter	MED	Advocate for medical research funding at the National Institutes of Health, National Cancer Institute, NIAMS, Centers for Disease Control and Prevention, Agency for Healthcare Research and Quality, and Food and Drug Administration in FY19 Labor/HHS/Education Appropriations (H.R. 6470/S. 3158; H.R. 6157). Advocate for The National Hansens Disease Program funding in FY19 Labor/HHS/Education Appropriations (H.R. 6470, S. 3158; H.R. 6157). Support funding for Directed Medical Research Programs (CDMRP) at the Department of Defense (DoD) in the Fiscal Year 2019 (FY19) Defense Appropriations bill (H.R. 6157, S. 3159). Support dedicated Melanoma research funding, outside of the Peer-Reviewed Cancer Research Program, at the DoD (H.R. 6157). Lobby members of Congress to direct the FDA to issue rulemaking pertaining to physicians access to compounded medications for use in the physician office setting (H.R. 3268). Support maintaining the Prevention and Public Health Fund (PPHF).	Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE		500000	0	0	2018-10-22T11:50:44.917000-04:00